Artelo LOGO.jpg
Artelo Biosciences, Inc. to Present at the Q1 Virtual Investor Summit on March 23rd
11. März 2021 07:10 ET | Artelo Biosciences, Inc.
LA JOLLA, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing therapeutics that modulate...